Sritharan S, Sivalingam N. A complete evaluate on time-tested anticancer drug doxorubicin. Life Sci. 2021;278:119527.
Hu LF, Lan HR, Li XM, Jin KT. A scientific evaluate of the potential chemoprotective results of resveratrol on doxorubicin-induced cardiotoxicity: give attention to the antioxidant, antiapoptotic, and anti-Inflammatory actions. Oxid Med Cell Longev. 2021 (2021) 2951697.
Yang G, Li M, Music T, Chen X, Zhang H, Wei X, Li N, Li T, Qin X, Li S, You F, Wu C, Zhang W, Liu Y, Yang H. Polydopamine-engineered theranostic nanoscouts enabling intracellular HSP90 mRNAs fluorescence detection for imaging-guided chemo-photothermal remedy. Adv Healthc Mater. 2022;11:e2201615.
Wang W, Chen C, Ying Y, Lv S, Wang Y, Zhang X, Cai Z, Gu W, Li Z, Jiang G, Gao F. Sensible PdH@MnO2 yolk-shell nanostructures for spatiotemporally synchronous focused hydrogen supply and oxygen-elevated phototherapy of melanoma. ACS Nano. 2022;16:5597–614.
Tan X, Luo S, Lengthy L, Wang Y, Wang D, Fang S, Ouyang Q, Su Y, Cheng T, Shi C. Construction-guided design and synthesis of a mitochondria-targeting near-infrared fluorophore with multimodal therapeutic actions. Adv Mater. 2017;29:1704196.
Wang H, Li X, Tse BW, Yang H, Thorling CA, Liu Y, Touraud M, Chouane JB, Liu X, Roberts MS. Liang. Indocyanine green-incorporating nanoparticles for most cancers theranostics. Theranostics. 2018;8:1227–42.
Ye S, Wang F, Fan Z, Zhu Q, Tian H, Zhang Y, Jiang B, Hou Z, Li Y, Su G. Mild/pH-triggered biomimetic crimson blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal remedy. ACS Appl Mater Interfaces. 2019;11:15262–75.
Li T, Geng Y, Zhang H, Wang J, Feng Y, Chen Z, Xie X, Qin X, Li S, Wu C, Liu Y. Yang. A flexible nanoplatform for synergistic chemo-photothermal remedy and multimodal imaging towards breast most cancers. Professional Opin Drug Deliv. 2020;17:725–33.
Solar X, He G, Xiong C, Wang C, Lian X, Hu L, Li Z, Dalgarno SJ, Yang YW, Tian J. One-pot fabrication of hole porphyrinic MOF nanoparticles with ultrahigh drug loading towards managed supply and synergistic most cancers remedy. ACS Appl Mater Interfaces. 2021;13:3679–93.
Chen QB, Shen MH, Ren XH, Zhu S, Shang JT, Liu W, Zhang ZW, Dong ZJ, Gu HZ, Zhang XZ, Yuan Q, Zou T. Tumor-triggered focusing on ammonium bicarbonate liposomes for tumor multimodal remedy. J Mater Chem B. 2022;10:5154–64.
Feng Y, Xie X, Zhang H, Su Q, Yang G, Wei X, Li N, Li T, Qin X, Li S, Wu C, Zheng C, Zhu J, You F, Wang G, Yang H. Liu. Multistage-responsive nanovehicle to enhance tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy. Biomaterials. 2021;275:120990.
Zhang X, Ong’achwa Machuki J, Pan W, Cai W, Xi Z, Shen F, Zhang L, Yang Y, Gao F, Guan M. Carbon nitride hole theranostic nanoregulators executing laser-activatable water splitting for enhanced ultrasound/fluorescence imaging and cooperative phototherapy. ACS Nano. 2020;14:4045–60.
Yi H, Lu W, Liu F, Zhang G, Xie F, Liu W, Wang L, Zhou W, Cheng Z. ROS-responsive liposomes with NIR light-triggered doxorubicin launch for combinatorial remedy of breast most cancers. J Nanobiotechnol. 2021;19:134.
Peng L, Mei X, He J, Xu J, Zhang W, Liang R, Wei M, Evans DG. Duan. Monolayer nanosheets with a particularly excessive drug loading towards managed supply and most cancers theranostics. Adv Mater. 2018;30:e1707389.
Du RR, Cedrone E, Romanov A, Falkovich R, Dobrovolskaia MA. Bathe. Innate immune stimulation utilizing 3D wireframe DNA origami. ACS Nano. 2022;16:20340–52.
Hu Q, Li H, Wang L, Gu H, Fan C. DNA nanotechnology-enabled drug supply techniques. Chem Rev. 2019;119:6459–506.
Xie X, Feng Y, Zhang H, Su Q, Music T, Yang G, Li N, Wei X, Li T, Qin X, Li S, Wu C, Zhang X, Wang G, Liu Y, Yang H. Transforming tumor immunosuppressive microenvironment by way of a novel bioactive nanovaccines potentiates the efficacy of most cancers immunotherapy. Bioact Mater. 2022;16:107–19.
Lucas CR, Halley PD, Chowdury AA, Harrington BK, Beaver L, Lapalombella R, Johnson AJ, Hertlein EK, Phelps MA, Byrd JC, Castro CE. DNA origami nanostructures elicit dose-dependent immunogenicity and are unhazardous as much as excessive doses in vivo. Small. 2022;18:e2108063.
Dong Y, Yao C, Zhu Y, Yang L, Luo D, Yang D. DNA useful supplies assembled from branched DNA: design, synthesis, and purposes. Chem Rev. 2020;120:9420–81.
He L, Mu J, Gang O, Chen X. Rationally programming nanomaterials with DNA for biomedical purposes. Adv Sci (Weinh). 2021;8:2003775.
Liu Y, Cheng J, Fan S, Ge H, Luo T, Tang L, Ji B, Zhang C, Cui D, Ke Y. Music. Modular reconfigurable DNA origami: from two-dimensional to three-dimensional buildings. Angew Chem Int Ed Engl. 2020;59:23277–82.
Strauss MT, Schueder F, Haas D, Nickels PC. Jungmann. Quantifying absolute addressability in DNA origami with molecular decision. Nat Commun. 2018;9:1600.
Aliouat H, Peng Y, Waseem Z, Wang S, Zhou W. Pure DNA scaffolded drug supply techniques for most cancers remedy. Biomaterials. 2022;285:121532.
Rothemund PW. Folding DNA to create nanoscale shapes and patterns. Nature. 2006;440:297–302.
Hong F, Zhang F, Liu Y, Yan H. DNA origami: scaffolds for creating larger order buildings. Chem Rev. 2017;117:12584–640.
Abe Ok, Sugiyama H, Endo M. Building of an optically controllable CRISPR-Cas9 system utilizing a DNA origami nanostructure. Chem Commun (Camb). 2021;57:5594–6.
Liu S, Jiang Q, Zhao X, Zhao R, Wang Y, Wang Y, Liu J, Shang Y, Zhao S, Wu T, Zhang Y, Nie G. Ding. A DNA nanodevice-based vaccine for most cancers immunotherapy. Nat Mater. 2021;20:421–30.
Wang Z, Music L, Liu Q, Tian R, Shang Y, Liu F, Liu S, Zhao S, Han Z, Solar J, Jiang Q. Ding. A tubular DNA nanodevice as a siRNA/chemo-drug co-delivery car for mixed most cancers remedy. Angew Chem Int Ed Engl. 2021;60:2594–8.
Pan Q, Nie C, Hu Y, Yi J, Liu C, Zhang J, He M, He M, Chen T, Chu X. Aptamer-functionalized DNA origami for focused codelivery of antisense oligonucleotides and doxorubicin to boost remedy in drug-resistant most cancers cells. ACS Appl Mater Interfaces. 2020;12:400–9.
Yazdian-Robati R, Bayat P, Oroojalian F, Zargari M, Ramezani M, Taghdisi SM. Abnous. Therapeutic purposes of AS1411 aptamer, an replace evaluate. Int J Biol Macromol. 2020;155:1420–31.
Chen Z, Peng Y, Li Y, Xie X, Wei X, Yang G, Zhang H, Li N, Li T, Qin X, Li S, Wu C, You F, Yang H, Liu Y. Aptamer-dendrimer functionalized magnetic nano-octahedrons: theranostic drug/gene supply platform for near-infrared/magnetic resonance imaging-guided magnetochemotherapy. ACS Nano. 2021;15:16683–96.
Gregório AC, Lacerda M, Figueiredo P, Simões S, Dias S, Moreira JN. Assembly the wants of breast most cancers: a nucleolin’s perspective. Crit Rev Oncol Hematol. 2018;125:89–101.
Fonseca NA, Rodrigues AS, Rodrigues-Santos P, Alves V, Gregório AC, Valério-Fernandes Â, Gomes-da-Silva LC, Rosa MS, Moura V, Ramalho-Santos J, Simões S. Moreira. Nucleolin overexpression in breast most cancers cell sub-populations with completely different stem-like phenotype allows focused intracellular supply of synergistic drug mixture. Biomaterials. 2015;69:76–88.
Zhan Y, Zhang Y, Mao C, Li J, Zhao Y, Chen Y, Liu Z, Lin Y. Improved tumor infiltration and immunomodulation for tumor remedy: a pathway primarily based on tetrahedral framework nucleic acids coupled bacterial nanocells. Nano Lett. 2023;23:353–62.
Xiao D, Li Y, Tian T, Zhang T, Shi S, Lu B, Gao Y, Qin X, Zhang M, Wei W, Lin Y. Tetrahedral framework nucleic acids loaded with aptamer AS1411 for siRNA supply and gene silencing in malignant melanoma. ACS Appl Mater Interfaces. 2021;13:6109–18.
Wang Q, Ma Y, Lu Z, Yu H, Li Z. Co-delivery of chemotherapeutic medication and immune adjuvants by nanoscale DNA tetrahedrons for synergistic most cancers remedy. ACS Appl Nano Mater. 2022;5:101–6.
Wang P, Rahman MA, Zhao Z, Weiss Ok, Zhang C, Chen Z, Hurwitz SJ, Chen ZG, Shin DM, Ke Y. Visualization of the mobile uptake and trafficking of DNA origami nanostructures in most cancers cells. J Am Chem Soc. 2018;140:2478–84.
Reyes-Reyes EM, Teng Y, Bates PJ. A brand new paradigm for aptamer therapeutic AS1411 motion: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Most cancers Res. 2010;70:8617–29.
Liu X, Wu L, Wang L, Jiang W. A dual-targeting DNA tetrahedron nanocarrier for breast most cancers cell imaging and drug supply. Talanta. 2018;179:356–63.
Wu T, Liu Q, Cao Y, Tian R, Liu J. Ding. Multifunctional double-bundle DNA tetrahedron for environment friendly regulation of gene expression. ACS Appl Mater Interfaces. 2020;12:32461–7.
Zhang Q, Jiang Q, Li N, Dai L, Liu Q, Music L, Wang J, Li Y, Tian J, Ding B, Du Y. DNA origami as an in vivo drug supply car for most cancers remedy. ACS Nano. 2014;8:6633–43.
Xu T, Yu S, Solar Y, Wu S, Gao D, Wang M, Wang Z, Tian Y, Min Q, Zhu JJ. DNA origami frameworks enabled self-protective siRNA supply for twin enhancement of chemo-photothermal mixture remedy. Small. 2021;17:e2101780.
Wang Z, Ju Y, Ali Z, Yin H, Sheng F, Lin J, Wang B, Hou Y. Close to-infrared mild and tumor microenvironment twin responsive size-switchable nanocapsules for multimodal tumor theranostics. Nat Commun. 2019;10:4418.
Singh R, Letai A, Sarosiek Ok. Regulation of apoptosis in well being and illness: the balancing act of BCL-2 household proteins. Nat Rev Mol Cell Biol. 2019;20:175–93.
Walensky LD. Concentrating on BAX to drug demise immediately. Nat Chem Biol. 2019;15:657–65.
Kang MH, Reynolds CP. Bcl-2 inhibitors: focusing on mitochondrial apoptotic pathways in most cancers remedy. Clin Most cancers Res. 2009;15:1126–32.
Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for most cancers remedy utilizing BH3-mimetic medication. Nat Rev Most cancers. 2022;22:45–64.
Feng Y, Zhang H, Xie X, Chen Y, Yang G, Wei X, Li N, Li M, Li T, Qin X, Li S, You F, Wu C, Yang H, Liu Y. Cascade-activatable NO launch primarily based on GSH-detonated “nanobomb” for multi-pathways most cancers remedy. Mater right this moment Bio. 2022;14:100288.
Knight T, Luedtke D, Edwards H, Taub JW, Ge Y. A fragile stability – the BCL-2 household and its function in apoptosis, oncogenesis, and most cancers therapeutics. Biochem Pharmacol. 2019;162:250–61.
Tang L, Zhang A, Mei Y, Xiao Q, Xu X, Wang W. NIR light-triggered chemo-phototherapy by ICG functionalized MWNTs for synergistic tumor-targeted supply. Pharmaceutics. 2021;13:2145.
